A Drug Drug Interaction (DDI) Study of Selpercatinib and Dabigatran in Healthy Participants
Clinical trial NCT04782076 · COMPLETED
Trial details
- NCT number
- NCT04782076
- Sponsor
- Loxo Oncology, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-05
- Primary completion
- 2021-05-17
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.